famotidine has been researched along with Colitis, Mucous in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huertas-Ceballos, AA | 1 |
| Logan, S | 2 |
| Bennett, C | 2 |
| Macarthur, C | 2 |
| Martin, AE | 1 |
| Huertas-Ceballos, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Trial of Food Elimination Based on IgG Antibodies for Treatment of Functional Gastrointestinal Diseases (FGIDs) in Children[NCT02565355] | 60 participants (Actual) | Interventional | 2015-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for famotidine and Colitis, Mucous
| Article | Year |
|---|---|
WITHDRAWN: Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
Topics: Abdominal Pain; Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Famotidine; Humans; I | 2014 |
Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
Topics: Abdominal Pain; Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Famotidine; Humans; I | 2008 |